HROW EBITDA | Harrow, Inc.

Harrow, Inc. (HROW) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$11.01M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$22.08M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $14.75M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $11.41M; Depreciation and amortization (m).

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$11.01M	(m)	$70.66M	(m)	$491.00K*	-$9.76M*	$20.30M	$8.07M	$53.30M	$0.00
2026-03-31	Reported	(m)	-$22.08M	(m)	$44.20M	(m)	$194.00K	-$8.99M	$17.16M	$5.89M	$43.23M	$25.00K
2025-09-30	Reported	(m)	$14.75M	(m)	$71.64M	(m)	$210.00K*	$16.59M*	$17.71M	$3.32M	$35.86M	(m)
2025-06-30	Reported	(m)	$11.41M	(m)	$63.74M	(m)	$166.00K*	-$803.00K*	$16.23M	$2.87M	$33.23M	$0.00
2025-03-31	Reported	(m)	-$11.23M	(m)	$47.83M	(m)	$170.00K	$19.67M	$15.52M	$3.03M	$40.51M	(m)
2024-09-30	Reported	(m)	$1.32M	(m)	$49.26M	(m)	$604.00K*	$2.95M*	$12.02M	$2.27M	$33.65M	$20.00K
2024-06-30	Reported	(m)	$1.53M	(m)	$48.94M	(m)	$344.00K*	-$2.75M*	$12.54M	$3.05M	$31.82M	$655.00K
2024-03-31	Reported	(m)	-$6.93M	(m)	$34.59M	(m)	$92.00K	-$4.63M	$10.55M	$2.15M	$28.81M	(m)
2023-09-30	Reported	(m)	$1.74M	(m)	$34.27M	(m)	$520.00K*	-$1.21M*	$10.07M	$1.42M	$21.03M	$1.54M
2023-06-30	Reported	(m)	$2.35M	(m)	$33.47M	(m)	$250.00K*	$4.57M*	$10.00M	$1.16M	$19.96M	-$15.00K
2023-03-31	Reported	(m)	$1.21M	(m)	$26.10M	(m)	$496.00K	-$8.21M	$8.27M	$734.00K	$15.89M	-$288.00K
2022-09-30	Reported	(m)	-$94.00K	(m)	$22.82M	(m)	$1.05M*	-$410.00K*	$6.72M	$775.00K	$15.42M	$35.00K
2022-06-30	Reported	(m)	$1.69M	(m)	$23.32M	(m)	$260.00K*	$4.86M*	$6.53M	$914.00K	$14.19M	$40.00K
2022-03-31	Reported	(m)	$2.10M	(m)	$22.12M	(m)	$404.00K	$967.00K	$5.96M	$658.00K	$13.40M	(m)
2021-09-30	Reported	(m)	-$3.72M	(m)	$18.71M	(m)	$289.00K*	-$2.08M*	$4.95M	$6.13M	$11.36M	(m)
2021-06-30	Reported	(m)	$4.17M	(m)	$18.13M	(m)	$1.15M*	$5.44M*	$4.42M	$425.00K	$9.12M	(m)
2021-03-31	Reported	(m)	$2.92M	(m)	$15.44M	(m)	$211.00K	$3.21M	$3.77M	$592.00K	$8.16M	(m)
2020-09-30	Reported	(m)	$1.60M	(m)	$14.40M	(m)	$244.00K*	$2.67M*	$3.70M	$670.00K	$8.44M	(m)
2020-06-30	Reported	(m)	-$3.21M	(m)	$8.06M	(m)	$316.00K*	-$2.65M*	$3.20M	$749.00K	$6.95M	(m)
2020-03-31	Reported	(m)	-$628.00K	(m)	$11.82M	(m)	$220.00K	-$550.00K	$3.63M	$403.00K	$8.42M	(m)
2019-09-30	Reported	(m)	-$4.40M	(m)	$12.76M	(m)	$24.00K*	-$70.00K*	$4.06M	$444.00K	$8.61M	(m)
2019-06-30	Reported	(m)	-$767.00K	(m)	$13.52M	(m)	$352.00K*	$844.00K*	$5.22M	$810.00K	$8.25M	(m)
2019-03-31	Reported	(m)	-$556.00K	(m)	$12.29M	(m)	$213.00K	-$1.48M	$3.90M	$405.00K	$8.54M	(m)
2018-09-30	Reported	(m)	-$649.00K	(m)	$10.74M	(m)	$518.00K*	$323.00K*	$4.19M	$233.00K	$6.96M	(m)
2018-06-30	Reported	(m)	-$624.00K	(m)	$10.38M	(m)	$358.00K*	$1.36M*	$4.16M	$72.00K	$6.78M	(m)
2018-03-31	Reported	(m)	-$1.78M	(m)	$8.87M	(m)	$192.00K	-$965.00K	$4.07M	$87.00K	$6.49M	(m)
2017-09-30	Reported	(m)	-$2.76M	(m)	$6.48M	(m)	$266.00K*	-$2.22M*	$3.40M	$63.00K	$5.78M	-$28.00K
2017-06-30	Reported	(m)	-$3.02M	(m)	(m)	(m)	$172.00K*	-$2.31M*	$3.29M	$101.00K	$6.49M	-$28.00K
2017-03-31	Reported	(m)	-$4.23M	(m)	(m)	(m)	$150.00K	-$3.98M	(m)	$160.00K	$6.81M	-$28.00K
2016-09-30	Reported	(m)	-$4.61M	(m)	(m)	(m)	$795.00K*	-$3.91M*	(m)	$16.00K	(m)	(m)
2016-06-30	Reported	(m)	-$4.01M	(m)	(m)	(m)	$3.38M*	-$2.77M*	(m)	$76.00K	(m)	(m)
2016-03-31	Reported	(m)	-$3.75M	(m)	(m)	(m)	$2.37M	-$2.30M	(m)	$46.00K	(m)	(m)
2015-09-30	Reported	(m)	-$3.53M	(m)	(m)	(m)	$496.00K*	-$2.40M*	(m)	$93.00K	(m)	(m)
2015-06-30	Reported	(m)	-$3.48M	(m)	(m)	(m)	$180.00K*	-$3.17M*	(m)	$25.00K	(m)	(m)
2015-03-31	Reported	(m)	-$3.12M	(m)	(m)	(m)	$28.00K	-$2.27M	(m)	$181.00K	(m)	(m)
2014-09-30	Reported	(m)	-$2.46M	(m)	(m)	(m)	$77.00K*	-$1.79M*	(m)	$70.00K	(m)	(m)
2014-06-30	Reported	(m)	-$2.60M	(m)	(m)	(m)	$5.00K*	-$1.53M*	(m)	$36.00K	(m)	(m)
2014-03-31	Reported	(m)	-$2.33M	(m)	(m)	(m)	$10.00K	-$1.68M	(m)	$60.00K	$2.28M	(m)
2013-09-30	Reported	(m)	-$2.09M	(m)	(m)	(m)	$5.31K*	-$1.14M*	(m)	$469.48K	$1.62M	(m)
2013-06-30	Reported	(m)	-$2.23M	(m)	(m)	(m)	$3.72K*	-$1.00M*	(m)	$677.35K	$1.56M	(m)
2013-03-31	Reported	(m)	-$1.47M	(m)	(m)	(m)	$1.45K	-$1.06M	(m)	$455.10K	$1.02M	(m)
2012-09-30	Reported	(m)	-$1.25M	(m)	(m)	(m)	$0.00*	-$669.72K*	(m)	$303.67K	$946.38K	(m)
2012-06-30	Reported	(m)	-$1.12M	(m)	(m)	(m)	$701.00*	-$282.56K*	(m)	$133.61K	$984.67K	(m)
2012-03-31	Reported	(m)	-$351.92K	(m)	(m)	(m)	$14.61K	-$334.84K	(m)	$142.96K	$308.96K	(m)
2011-09-30	Reported	(m)	-$66.50K	(m)	(m)	(m)	$0.00*	-$30.94K*	(m)	$0.00	$66.50K	(m)
2011-06-30	Reported	(m)	-$145.77K	(m)	(m)	(m)	$0.00*	-$65.31K*	(m)	$24.34K	$121.43K	(m)
2011-03-31	Reported	(m)	-$413.82K	(m)	(m)	(m)	$0.00	-$220.60K	(m)	$87.22K	$326.60K	(m)
2010-09-30	Reported	(m)	-$727.77K	(m)	(m)	(m)	$0.00*	-$575.34K*	(m)	$142.79K	$584.98K	(m)
2010-06-30	Reported	(m)	-$496.76K	(m)	(m)	(m)	(m)	(m)	(m)	$86.95K	$409.81K	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$30.52M	(m)	$272.30M	(m)	$887.00K	$43.86M	$67.93M	$20.94M	$152.91M	$3.77M
2024-12-31	Reported	(m)	$8.82M	(m)	$199.61M	(m)	$1.59M	-$22.20M	$49.24M	$12.23M	$129.06M	$161.00K
2023-12-31	Reported	(m)	$431.00K	(m)	$130.19M	(m)	$1.46M	$3.84M	$39.64M	$6.65M	$83.09M	$701.00K
2022-12-31	Reported	(m)	$1.92M	(m)	$88.59M	(m)	$2.60M	$1.71M	$25.38M	$3.05M	$58.24M	$75.00K
2021-12-31	Reported	(m)	$1.61M	(m)	$72.48M	(m)	$1.79M	$5.08M	$18.21M	$11.08M	$41.31M	$133.00K
2020-12-31	Reported	(m)	$385.00K	(m)	$48.87M	(m)	$862.00K	-$1.10M	$14.46M	$2.41M	$31.25M	$4.00K
2019-12-31	Reported	(m)	-$4.79M	(m)	$51.16M	(m)	$1.47M	$950.00K	$16.75M	$2.08M	$33.09M	$8.00K
2018-12-31	Reported	(m)	-$5.22M	(m)	$41.37M	(m)	$1.77M	$687.00K	$16.52M	$825.00K	$29.24M	(m)
2017-12-31	Reported	(m)	-$12.16M	(m)	$26.77M	(m)	$772.00K	-$8.80M	$13.51M	$413.00K	$25.02M	-$935.00K
2016-12-31	Reported	(m)	-$15.88M	(m)	(m)	(m)	$6.89M	-$11.21M	(m)	$739.00K	(m)	-$111.00K
2015-12-31	Reported	(m)	-$14.82M	(m)	(m)	(m)	-$995.00K	-$11.14M	(m)	$332.00K	(m)	$5.00K
2014-12-31	Reported	(m)	-$10.15M	(m)	(m)	(m)	$174.00K	-$7.06M	(m)	$237.00K	(m)	$3.00K
2013-12-31	Reported	(m)	-$7.69M	(m)	(m)	(m)	$20.00K	-$4.44M	(m)	$1.62M	$6.08M	(m)
2012-12-31	Reported	(m)	-$4.18M	(m)	(m)	(m)	$15.49K	-$1.90M	(m)	$1.30M	$2.98M	$1.60K
2011-12-31	Reported	(m)	-$939.23K	(m)	(m)	(m)	$0.00	-$291.16K	(m)	$111.55K	$827.67K	$0.00
2010-12-31	Reported	(m)	-$2.50M	(m)	(m)	(m)	$0.00	-$2.30M	(m)	$194.59K	$2.31M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Damora Therapeutics, Inc. (DMRA)		$1.250B	-6.10
OPKO HEALTH, INC. (OPK)	United States	$1.220B	-15.59
LB PHARMACEUTICALS INC (LBRX)	United States	$1.220B	-10.87
Avalyn Pharma Inc. (AVLN)	United States	$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)	United States	$1.280B
Jaguar Health, Inc. (JAGX)	United States	$1.184B
Latigo Biotherapeutics, Inc. (LTGO)	United States	$1.176B
Bicara Therapeutics Inc. (BCAX)	United States	$1.309B	-10.55
Tyra Biosciences, Inc. (TYRA)	United States	$1.337B	-12.83
Kardigan, Inc. (KARD)	United States	$1.346B